$8.62
-0.13-1.49%
At close: -
$8.62
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Arcus Biosciences Earnings Estimates, EPS & Revenue | NYSE:RCUS | Benzinga
Arcus Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-1.010
Quarterly Revenue Estimate
$38.41M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$258.00M
Analyze the earnings history of Arcus Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RCUS | Arcus Biosciences | -$0.05 | -$1.01 | — | — | $145.00M | $38.41M | — | — | 05/06/2025 | Get Alert |
| RCUS | Arcus Biosciences | -$1.08 | -$1.20 | -$1.03 | 14.17% | $31.00M | $29.38M | $36.00M | 22.53% | 02/25/2025 | Get Alert |
| RCUS | Arcus Biosciences | -$0.94 | -$1.06 | -$1.00 | 5.66% | $32.00M | $37.56M | $48.00M | 27.80% | 11/06/2024 | Get Alert |
| RCUS | Arcus Biosciences | -$1.04 | -$1.10 | -$1.02 | 7.27% | $29.00M | $25.61M | $39.00M | 52.28% | 08/08/2024 | Get Alert |
| RCUS | Arcus Biosciences | -$1.09 | -$0.93 | -$0.05 | 94.62% | $25.00M | $35.56M | $145.00M | 307.76% | 05/08/2024 | Get Alert |
| RCUS | Arcus Biosciences | -$0.93 | -$1.02 | -$1.08 | -5.88% | $34.00M | $28.37M | $31.00M | 9.27% | 02/21/2024 | Get Alert |
| RCUS | Arcus Biosciences | -$0.90 | -$1.14 | -$0.94 | 17.54% | $33.58M | $27.28M | $32.00M | 17.30% | 11/07/2023 | Get Alert |
| RCUS | Arcus Biosciences | -$0.93 | -$1.00 | -$1.04 | -4.00% | $26.76M | $35.86M | $29.00M | -19.13% | 08/07/2023 | Get Alert |
| RCUS | Arcus Biosciences | -$0.96 | -$1.16 | -$1.09 | 6.03% | $18.00M | $24.97M | $25.00M | 0.12% | 05/09/2023 | Get Alert |
| RCUS | Arcus Biosciences | $3.71 | -$1.07 | -$0.93 | 13.08% | $354.50M | $23.31M | $34.00M | 45.86% | 02/28/2023 | Get Alert |
| RCUS | Arcus Biosciences | -$1.11 | -$1.04 | -$0.90 | 13.46% | $9.46M | $21.89M | $33.58M | 53.41% | 11/02/2022 | Get Alert |
| RCUS | Arcus Biosciences | -$1.09 | -$0.94 | -$0.93 | 1.06% | $9.46M | $21.12M | $26.76M | 26.70% | 08/03/2022 | Get Alert |
| RCUS | Arcus Biosciences | -$1.08 | -$0.31 | -$0.96 | -209.68% | $9.46M | $79.42M | $18.00M | -77.33% | 05/09/2022 | Get Alert |
| RCUS | Arcus Biosciences | -$0.82 | -$0.74 | $3.71 | 601.35% | $9.49M | $39.39M | $354.50M | 799.97% | 02/23/2022 | Get Alert |
| RCUS | Arcus Biosciences | $0.03 | -$1.08 | -$1.11 | -2.78% | $64.53M | $9.40M | $9.46M | 0.65% | 11/08/2021 | Get Alert |
| RCUS | Arcus Biosciences | -$0.93 | -$0.88 | -$1.09 | -23.86% | $1.75M | $13.05M | $9.46M | -27.50% | 08/05/2021 | Get Alert |
| RCUS | Arcus Biosciences | -$0.63 | -$0.84 | -$1.08 | -28.57% | $1.75M | $13.34M | $9.46M | -29.08% | 05/05/2021 | Get Alert |
| RCUS | Arcus Biosciences | -$0.38 | -$0.75 | -$0.82 | -9.33% | $9.75M | $7.93M | $9.49M | 19.63% | 02/24/2021 | Get Alert |
| RCUS | Arcus Biosciences | -$0.51 | $0.05 | $0.03 | -40.00% | $1.75M | $48.15M | $64.53M | 34.02% | 11/05/2020 | Get Alert |
| RCUS | Arcus Biosciences | -$0.64 | — | -$0.93 | — | $1.75M | — | $1.75M | — | 08/06/2020 | Get Alert |
| RCUS | Arcus Biosciences | -$0.41 | — | -$0.63 | — | $1.75M | — | $1.75M | — | 05/05/2020 | Get Alert |
Arcus Biosciences (RCUS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $-1.03 | $-1.20 | 14.2 % |
| Q3 | 2024-11-06 | $-1.00 | $-1.06 | 5.66 % |
| Q2 | 2024-08-08 | $-1.02 | $-1.10 | 7.27 % |
| Q1 | 2024-05-08 | $-0.05 | $-0.93 | 94.6 % |
Arcus Biosciences (RCUS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-25 | $36.00M | $29.38M | 22.5 % |
| Q3 | 2024-11-06 | $48.00M | $37.56M | 27.8 % |
| Q2 | 2024-08-08 | $39.00M | $25.61M | 52.3 % |
| Q1 | 2024-05-08 | $145.00M | $35.56M | 307.8 % |
FAQ
When is Arcus Biosciences (NYSE:RCUS) reporting earnings?
Arcus Biosciences (RCUS) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 25, 2025 for Q4.
What were the latest earnings per share (EPS) for Arcus Biosciences (NYSE:RCUS)?
The Actual EPS was $-1.03, which beat the estimate of $-1.20.
What were Arcus Biosciences’s (NYSE:RCUS) revenues?
The Actual Revenue was $36M, which beat the estimate of $29.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
